MYCITRACIN Drug Patent Profile
✉ Email this page to a colleague
When do Mycitracin patents expire, and what generic alternatives are available?
Mycitracin is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in MYCITRACIN is bacitracin; neomycin sulfate; polymyxin b sulfate. There is one drug master file entry for this compound. Additional details are available on the bacitracin; neomycin sulfate; polymyxin b sulfate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MYCITRACIN?
- What are the global sales for MYCITRACIN?
- What is Average Wholesale Price for MYCITRACIN?
Summary for MYCITRACIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 20 |
| Patent Applications: | 2,804 |
| DailyMed Link: | MYCITRACIN at DailyMed |
US Patents and Regulatory Information for MYCITRACIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | MYCITRACIN | bacitracin; neomycin sulfate; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 061048-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
